Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis von Comenzo, R L, Reece, D, Palladini, G, Seldin, D, Sanchorawala, V, Landau, H, Falk, R, Wells, K, Solomon, A, Wechalekar, A, Zonder, J, Dispenzieri, A, Gertz, M, Streicher, H, Skinner, M, Kyle, R A, Merlini, G

Volltext

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma von Rajkumar, S V, Gupta, V, Fonseca, R, Dispenzieri, A, Gonsalves, W I, Larson, D, Ketterling, R P, Lust, J A, Kyle, R A, Kumar, S K

Volltext

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma von Larsen, J T, Kumar, S K, Dispenzieri, A, Kyle, R A, Katzmann, J A, Rajkumar, S V

Volltext

N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression von Dispenzieri, Angela, Larson, D. R., Rajkumar, S. V., Kyle, R. A., Kumar, S. K., Kourelis, Taxiarchis, Arendt, Bonnie, Willrcih, Maria, Dasari, Surendra, Murray, David

Volltext

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines fo... von Kyle, R A, Durie, B G M, Rajkumar, S V, Landgren, O, Blade, J, Merlini, G, Kröger, N, Einsele, H, Vesole, D H, Dimopoulos, M, San Miguel, J, Avet-Loiseau, H, Hajek, R, Chen, W M, Anderson, K C, Ludwig, H, Sonneveld, P, Pavlovsky, S, Palumbo, A, Richardson, P G, Barlogie, B, Greipp, P, Vescio, R, Turesson, I, Westin, J, Boccadoro, M

Volltext

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents von Majithia, N, Rajkumar, S V, Lacy, M Q, Buadi, F K, Dispenzieri, A, Gertz, M A, Hayman, S R, Dingli, D, Kapoor, P, Hwa, L, Lust, J A, Russell, S J, Go, R S, Kyle, R A, Kumar, S K

Volltext

Genetic aberrations and survival in plasma cell leukemia von Tiedemann, R E, Gonzalez-Paz, N, Kyle, R A, Santana-Davila, R, Price-Troska, T, Van Wier, S A, Chng, W J, Ketterling, R P, Gertz, M A, Henderson, K, Greipp, P R, Dispenzieri, A, Lacy, M Q, Rajkumar, S V, Bergsagel, P L, Stewart, A K, Fonseca, R

Volltext

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma von Bianchi, G, Kyle, R A, Larson, D R, Witzig, T E, Kumar, S, Dispenzieri, A, Morice, W G, Rajkumar, S V

Volltext

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma von Short, K Detweiler, Rajkumar, S V, Larson, D, Buadi, F, Hayman, S, Dispenzieri, A, Gertz, M, Kumar, S, Mikhael, J, Roy, V, Kyle, R A, Lacy, M Q

Volltext

Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design von Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.

Volltext

Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design von Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.

Volltext

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group von Fernández de Larrea, C, Kyle, R A, Durie, B G M, Ludwig, H, Usmani, S, Vesole, D H, Hajek, R, San Miguel, J F, Sezer, O, Sonneveld, P, Kumar, S K, Mahindra, A, Comenzo, R, Palumbo, A, Mazumber, A, Anderson, K C, Richardson, P G, Badros, A Z, Caers, J, Cavo, M, LeLeu, X, Dimopoulos, M A, Chim, C S, Schots, R, Noeul, A, Fantl, D, Mellqvist, U-H, Landgren, O, Chanan-Khan, A, Moreau, P, Fonseca, R, Merlini, G, Lahuerta, J J, Bladé, J, Orlowski, R Z, Shah, J J

Volltext

Clinically relevant end points and new drug approvals for myeloma von Anderson, K C, Kyle, R A, Rajkumar, S V, Stewart, A K, Weber, D, Richardson, P

Volltext

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system von Snozek, C L H, Katzmann, J A, Kyle, R A, Dispenzieri, A, Larson, D R, Therneau, T M, Melton, L J, Kumar, S, Greipp, P R, Clark, R J, Rajkumar, S V

Volltext

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma von Binder, M, Rajkumar, S V, Ketterling, R P, Greipp, P T, Dispenzieri, A, Lacy, M Q, Gertz, M A, Buadi, F K, Hayman, S R, Hwa, Y L, Zeldenrust, S R, Lust, J A, Russell, S J, Leung, N, Kapoor, P, Go, R S, Gonsalves, W I, Kyle, R A, Kumar, S K

Volltext

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma von Kaufman, G P, Gertz, M A, Dispenzieri, A, Lacy, M Q, Buadi, F K, Dingli, D, Hayman, S R, Kapoor, P, Lust, J A, Russell, S, Go, R S, Hwa, Y L, Kyle, R A, Rajkumar, S V, Kumar, S K

Volltext

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients von Visram, A., Soof, C., Rajkumar, S. V., Kumar, S. K., Bujarski, S., Spektor, T. M., Kyle, R. A., Berenson, J. R., Dispenzieri, A.

Volltext

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience von Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hayman, S., Kourelis, T., Warsame, R., Hwa, Y., Fonder, A., Hobbs, M., Muchtar, E., Leung, N., Kapoor, P., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.

Volltext

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy von STEWART, A. K, BERGSAGEL, P. L, WITZIG, T. E, ZELDENRUST, S. R, DINGLI, D, REEDER, C. B, ROY, V, KYLE, R. A, RAJKUMAR, S. V, FONSECA, R, GREIPP, P. R, DISPENZIERI, A, GERTZ, M. A, HAYMAN, S. R, KUMAR, S, LACY, M. Q, LUST, J. A, RUSSELL, S. J

Volltext

Clinical and biological significance of RAS mutations in multiple myeloma von Chng, W J, Gonzalez-Paz, N, Price-Troska, T, Jacobus, S, Rajkumar, S V, Oken, M M, Kyle, R A, Henderson, K J, Van Wier, S, Greipp, P, Van Ness, B, Fonseca, R

Volltext